Press Releases

Filters
March 23, 2017

Debiopharm International uses cutting-edge ClinTrial App mobile application from ClinOne in clinical study

Read more
March 10, 2017

Debiopharm International SA Appeals to the Supreme Court regarding Towa Pharmaceutical Co., Ltd. case

Read more
February 21, 2017

Debiopharm International SA Appeals to the Supreme Court regarding Nippon Kayaku Co., Ltd. case

Read more
January 10, 2017

Debiopharm International SA Announces positive Phase 2 Clinical Trial with Debio 1450 in ABSSSI patients

Read more
January 9, 2017

Debiopharm Group’s Triptorelin 6-month Formulation Receives Approval for the Treatment of Central Precocious Puberty (CPP) in Europe

Read more
October 25, 2016

Debiopharm International SA Reaches Important Development Milestones for its Staphylococcus-selective antibiotic Debio 1450

Read more
October 20, 2016

Debiopharm International SA Announces Clinical Collaboration with the Merck-Pfizer Alliance in Cancer Immunotherapy

Read more
June 7, 2016

Debiopharm International SA initiates clinical phase II study evaluating Debio 1143 in Ovarian Cancer

Read more
June 2, 2016

FDA grants Orphan Drug Designation to Debiopharm International SA’s IAP inhibitor Debio 1143 in the treatment of ovarian cancer

Read more